Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionFormulation of 3 humanized mAbs that binds to distinct regions of Clostridium botulinum toxin type A
Molecular Target C. botulinum toxin type A
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Infectious (unspecified)
Indication DetailsNeutralize C. botulinum toxin type A; Treat and prevent botulism poisoning; Treat botulism poisoning
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today